Avadel Pharmaceuticals PLC (AVDL)
14.29
-0.28
(-1.92%)
USD |
NASDAQ |
Jun 25, 16:00
14.29
0.00 (0.00%)
After-Hours: 20:00
Avadel Pharmaceuticals Cash from Operations (Quarterly): -29.70M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -29.70M |
| December 31, 2023 | -28.03M |
| September 30, 2023 | -38.23M |
| June 30, 2023 | -32.02M |
| March 31, 2023 | -30.23M |
| December 31, 2022 | -15.37M |
| September 30, 2022 | -6.803M |
| June 30, 2022 | -14.09M |
| March 31, 2022 | -34.04M |
| December 31, 2021 | -22.51M |
| September 30, 2021 | -21.24M |
| June 30, 2021 | -10.15M |
| March 31, 2021 | -23.41M |
| December 31, 2020 | -19.12M |
| September 30, 2020 | -10.19M |
| June 30, 2020 | -7.781M |
| March 31, 2020 | -11.64M |
| December 31, 2019 | -8.253M |
| September 30, 2019 | -7.419M |
| June 30, 2019 | -1.447M |
| March 31, 2019 | -21.21M |
| December 31, 2018 | -24.53M |
| September 30, 2018 | -20.25M |
| June 30, 2018 | -19.93M |
| March 31, 2018 | -18.01M |
| Date | Value |
|---|---|
| December 31, 2017 | -13.82M |
| September 30, 2017 | -3.058M |
| June 30, 2017 | 8.228M |
| March 31, 2017 | 25.31M |
| December 31, 2016 | 7.741M |
| September 30, 2016 | -4.761M |
| June 30, 2016 | -4.448M |
| March 31, 2016 | 20.37M |
| December 31, 2015 | 26.40M |
| September 30, 2015 | 18.59M |
| June 30, 2015 | 14.03M |
| March 31, 2015 | 25.28M |
| December 31, 2014 | -6.311M |
| September 30, 2014 | 3.497M |
| June 30, 2014 | -5.405M |
| March 31, 2014 | -2.398M |
| December 31, 2013 | -7.018M |
| September 30, 2013 | -0.196M |
| June 30, 2013 | -5.864M |
| March 31, 2013 | -7.598M |
| December 31, 2012 | -6.22M |
| September 30, 2012 | -5.648M |
| June 30, 2012 | -6.686M |
| March 31, 2012 | -4.585M |
| December 31, 2011 | -3.721M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-38.23M
Minimum
Sep 2023
-1.447M
Maximum
Jun 2019
-18.58M
Average
-17.25M
Median
Cash from Operations (Quarterly) Benchmarks
| Trinity Biotech PLC | -2.819M |
| Amarin Corp PLC | -12.60M |
| Medtronic PLC | 2.777B |
| Biodexa Pharmaceuticals Plc | -- |
| Akari Therapeutics PLC | -4.044M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 21.39M |
| Cash from Financing (Quarterly) | 13.19M |
| Free Cash Flow | -127.98M |
| Free Cash Flow Per Share (Quarterly) | -0.324 |
| Free Cash Flow to Equity (Quarterly) | -29.70M |
| Free Cash Flow to Firm (Quarterly) | -27.10M |
| Free Cash Flow Yield | -10.29% |